Hearing loss disorders associated with renal disease

Advances in Oto-Rhino-Laryngology

Volumn 70, Issue , 2011, Pages 75-83

  Kimberling, William J ^a,b,d   Borsa, Nicolo ^c   Smith, Richard J H ^b  

^a BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d Boys Town Natl Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; EYA1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE;

ARTICLE; BRANCHIOOTORENAL SYNDROME; DIFFERENTIAL DIAGNOSIS; GENETIC COUNSELING; GENETICS; HEREDITY; HUMAN; MUTATION; NEPHRITIS; PATIENT REFERRAL;

BRANCHIO-OTO-RENAL SYNDROME; COLLAGEN TYPE IV; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; HEREDITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; NEPHRITIS, HEREDITARY; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; REFERRAL AND CONSULTATION;

EID: 79952366272     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000322478     Document Type: Article

References (65)

1. Reiners J, Nagel- Wolfrum K, Jurgens K, Marker T, Wolfrum U: Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease. Exp Eye Res 2006;83:97-119. (Pubitemid 43783252)
2. Melnick M, Bixler D, Nance WE, Silk K, Yune H: Familial branchio- otorenal dysplasia: a new addition to the branchial arch syndromes. Clin Genet 1976;9:25-34.
3. Chang EH, Menezes M, Meyer NC, et al: Branchio- oto- renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004;23:582-589. (Pubitemid 38720610)
4. Orten DJ, Fischer SM, Sorensen JL, et al: Branchio- oto- renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum Mutat 2008;29:537-544. (Pubitemid 351536993)
5. Cremers CWRJ, Fikkers- Van Noord M: The earpits- deafness syndrome: clinical and genetic aspects. Int J Pediatr Otorhinolaryngol 1980;2:309-322. (Pubitemid 11164431)
6. Fraser FC, Ling D, Clogg D, Nogrady B: Genetic aspects of the BOR syndrome - branchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978;2:241-252. (Pubitemid 9086016)
7. Cremers CWRJ, Thijssen HOM, Fischer AJEM, Marres EHMA: Otological aspects of the earpit- deafness syndrome. ORL 1981;43:223-239. (Pubitemid 11127597)
8. Fitch N, Lindsay JR, Srolovitz H: The temporal bone in the preauricular pit, cervical fistula, hearing loss syndrome. Ann Otol 1976;85:268-275.
9. Chen A, Francis M, Ni L, et al: Phenotypic manifestations of branchiooto- renal syndrome. Am J Med Genet 1995;58:365-370.
10. Ceruti S, Stinckens C, Cremers CW, Casselman JW: Temporal bone anomalies in the branchio- oto- renal syndrome: detailed computed tomographic and magnetic resonance imaging findings. Otol Neurotol 2002;23:200-207. (Pubitemid 34208586)
11. Heimler A, Lieber E: BOR syndrome: reduced penetrance and variable expressivity in 4 generations of a large kindred. Am J Med Genet 1986;25:15-27. (Pubitemid 16044579)
12. Fraser FC, Ayme S, Halal F, Sproule JR: Autosomal dominant duplication of the renal collecting system, hearing loss, and external ear anomalies: a new syndrome? Am J Med Gen 1983;14:473-478. (Pubitemid 13108936)
13. Fraser FC, Sproule JR, Halal F: Frequency of the branchio- oto- renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980;7:341-349. (Pubitemid 11203638)
14. Raspino M, Tarantino V, Moni L, Verrina E, Ciardi MR, Gusmano R: The branchio- oto- renal syndrome: report of 2 family groups. J Laryngol Otol 1988; 102:138-141. (Pubitemid 18065232)
15. Abdelhak S, Kalatzis V, Heilig R, et al: Clustering of mutations responsible for branchio- oto- renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet 1997; 6:2247-2255. (Pubitemid 27501076)
16. Abdelhak S, Kalatzis V, Heilig R, et al: A human homologue of the Drosophila eyes absent gene underlies branchio- otorenal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997;15: 157-164.
17. Smith RJ, Coppage KB, Ankerstjerne JK, et al: Localization of the gene for branchiootorenal syndrome to chromosome 8q. Genomics 1992;14:841-844. (Pubitemid 23053018)
18. Hoskins BE, Cramer CH, Silvius D, et al: Transcription factor SIX5 is mutated in patients with branchio- oto- renal syndrome. Am J Hum Genet 2007;80:800-804. (Pubitemid 46564416)
19. Ruf RG, Xu PX, Silvius D, et al: SIX1 mutations cause branchio- oto- renal syndrome by disruption of EYA1- SIX1- DNA complexes. Proc Natl Acad Sci USA 2004;101:8090-8095. (Pubitemid 38698059)
20. Chai L, Yang J, Di C, et al: Transcriptional activation of the SALL1 by the human SIX1 homeodomain during kidney development. J Biol Chem 2006;281:18918-18926. (Pubitemid 44035394)
21. Albrecht B, Liebers M, Kohlhase J: Atypical phenotype and intrafamilial variability associated with a novel SALL1 mutation. Am J Med Gen 2004;125A: 102-104. (Pubitemid 38166544)
22. Engels S, Kohlhase J, McGaughran J: A SALL1 mutation causes a branchio- otorenal syndrome- like phenotype. J Med Genet 2000;37:458-460. (Pubitemid 30386741)
23. Botzenhart EM, Bartalini G, Blair E, et al: Townes- Brocks syndrome: twenty novel SALL1 mutations in sporadic and familial cases and refinement of the SALL1 hot spot region. Hum Mutat 2007;28:204-205.
24. Flinter F: Alport syndrome: a clinical and genetic study. Contrib Nephrol. Basel, Karger, 1990, vol 80, pp 9- 16.
25. Gleeson MJ: Alport syndrome: audiological manifestations and implications. J Laryngol Otol 1984;98:449-465. (Pubitemid 14129052)
26. Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M: Genetics of classic Alport syndrome. Lancet 1988;ii: 1005-1007.
27. Gubler MC, Antignac C, Deschenes G, et al: Genetic, clinical, and morphologic heterogeneity in Alport syndrome. Adv Nephrol Necker Hosp 1993;22:15-35.
28. Gubler MC: Inherited diseases of the glomerular basement membrane. Nat Clin Pract Nephrol 2008;4:24-37. (Pubitemid 350308222)
29. Grunfeld JP, Charbonneau R, Grateau G, Noel LH: Alport syndrome and related hereditary nephropathies. Contrib Nephrol. Basel, Karger, 1988, vol 61, pp 82- 90.
30. Jais JP, Knebelmann B, Giatras I, et al: X- linked Alport syndrome: natural history and genotype- phenotype correlations in girls and women belonging to 195 families: a European Community Alport Syndrome Concerted Action study. J Am Soc Nephrol 2003;14:2603-2610. (Pubitemid 37169346)
31. Thorner PS: Alport syndrome and thin basement membrane nephropathy. Nephron Clin Pract 2007;106:c82-c88. (Pubitemid 46933396)
32. Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM: Retinal findings in patients with Alport syndrome: expanding the clinical spectrum. Br J Ophthalmol 2009; 93:1606-1611.
33. Barker DF, Hostikka SL, Zhou J, et al: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990;248:1224-1227.
34. Kleppel MM, Kashtan C, Santi PA, Wieslander J, Michael AF: Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis: relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen. Lab Invest 1989;61:278-289. (Pubitemid 19249641)
35. Kleppel MM, Fan WW, Cheong HI, Kashtan CE, Michael AF: Immunochemical studies of the Alport antigen. Kidney Int 1992;41:1629-1637.
36. Lemmink HH, Mochizuki T, van den Heuvel LP, et al: Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 1994;3:1269-1273. (Pubitemid 24255458)
37. Mochizuki T, Lemmink HH, Mariyama M, et al: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994;8:77-81. (Pubitemid 2122272)
38. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: structure, gene organization, and role in human diseases: molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993;268:26033-26036. (Pubitemid 23361657)
39. Garcia- Torres R, Cruz D, Orozco L, Heidet L, Gubler MC: Alport syndrome and diffuse leiomyomatosis: clinical aspects, pathology, molecular biology and extracellular matrix studies. A synthesis. Nephrologie 2000;21:9-12. (Pubitemid 30123190)
40. Piccini M, Vitelli F, Bruttini M, et al: FACL4, a new gene encoding long- chain acyl- CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 1998;47:350-358. (Pubitemid 28110647)
41. Gross O, Kashtan CE: Treatment of Alport syndrome: beyond animal models. Kidney Int 2009;76:599-603.
42. Imai E, Isaka Y: Perspectives for gene therapy in renal diseases. Intern Med 2004;43:85-96. (Pubitemid 38325157)
43. Kashtan CE: Renal transplantation in patients with Alport syndrome. Pediatr Transplant 2006;10:651-657. (Pubitemid 44186284)
44. Eccles MR, Schimmenti LA: Renalcoloboma syndrome: a multi- system developmental disorder caused by PAX2 mutations. Clin Genet 1999;56:1-9. (Pubitemid 29354006)
45. Ford B, Rupps R, Lirenman D, et al: Renal- coloboma syndrome: prenatal detection and clinical spectrum in a large family. Am J Med Genet 2001;99: 137-141. (Pubitemid 32204785)
46. Schimmenti LA, Cunliffe HE, McNoe LA, et al: Further delineation of renalcoloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 1997;60:869-878. (Pubitemid 27146495)
47. Sanyanusin P, Schimmenti LA, McNoe LA, et al: Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995;9:358-364.
48. Amiel J, Audollent S, Joly D, et al: PAX2 mutations in renal- coloboma syndrome: mutational hotspot and germline mosaicism. Eur J Hum Genet 2000;8:820-826.
49. Dureau P, Attie- Bitach T, Salomon R, et al: Renal coloboma syndrome. Ophthalmology 2001;108:1912-1916. (Pubitemid 32905956)
50. Epstein CJ, Sahud MA, Piel CF, et al: Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med 1972; 52:299-310.
51. Pecci A, Canobbio I, Balduini A, et al: Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations. Hum Mol Genet 2005; 14:3169-3178. (Pubitemid 41631292)
52. Pecci A, Panza E, Pujol- Moix N, et al: Position of nonmuscle myosin heavy chain IIA (NMMHC- IIA) mutations predicts the natural history of MYH9- related disease. Hum Mutat 2008;29: 409-417. (Pubitemid 351364943)
53. Muckle TJ, Wells SM: Urticaria, deafness, and amyloidosis: a new heredofamilial syndrome. Q J Med 1962;31: 235-248.
54. Aganna E, Martinon F, Hawkins PN, et al: Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46:2445-2452.
55. Aganna E, Hawkins PN, Ozen S, et al: Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun 2004;5:289-293. (Pubitemid 38961162)
56. Cohen T, Brand- Auraban A, Karshai C, et al: Familial infantile renal tubular acidosis and congenital nerve deafness: an autosomal recessive syndrome. Clin Genet 1973;4:275-278.
57. Karet FE, Finberg KE, Nelson RD, et al: Mutations in the gene encoding B1 subunit of H+- ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 1999;21:84-90. (Pubitemid 29036289)
58. Berrettini S, Forli F, Bogazzi F, et al: Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features. Am J Otolaryngol 2005; 26:363-371. (Pubitemid 41578853)
59. Berrettini S, Neri E, Forli F, et al: Large vestibular aqueduct in distal renal tubular acidosis: high- resolution MR in three cases. Acta Radiol 2001;42:320-322. (Pubitemid 33655064)
60. Andreucci E, Bianchi B, Carboni I, et al: Inner ear abnormalities in four patients with dRTA and SNHL: clinical and genetic heterogeneity. Pediatr Nephrol 2009;24:2147-2153.
61. Birkenhager R, Otto E, Schurmann MJ, et al: Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001;29: 310-314. (Pubitemid 33096457)
62. Landau D, Shalev H, Ohaly M, Carmi R: Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet 1995;59:454-459.
63. Schlingmann KP, Konrad M, Jeck N, et al: Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med 2004;350:1314-1319. (Pubitemid 38375366)
64. Jeck N, Reinalter SC, Henne T, et al: Hypokalemic salt- losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 2001;108: E5.
65. Bitner- Glindzicz M, Heath KE, Campos- Barros A: Genetic hearing loss associated with renal disorders; in Toriello HV, Reardon W, Gorlin RJ (eds): Hereditary Hearing Loss and its Syndromes, ed 2. New York, Oxford University Press, 2004, pp 267- 289.